Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes
- PMID: 34818491
- DOI: 10.1056/NEJMc2115776
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes
Comment in
-
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Reply.N Engl J Med. 2021 Nov 25;385(22):2107. doi: 10.1056/NEJMc2115776. N Engl J Med. 2021. PMID: 34818492 No abstract available.
Comment on
-
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical